Lv5
1090 积分 2024-11-22 加入
Safety and Efficacy of Triple Therapy Containing Encorafenib, Cetuximab, and Binimetinib for BRAF V600E-Mutated Colorectal Cancer: a Systematic Review and Meta-Analysis
28天前
已完结
[A retrospective study of BRAF inhibitors and EGFR inhibitors combined with immune checkpoint inhibitors in patients with microsatellite stable, BRAF V600E mutated metastatic colorectal cancer]
29天前
已完结
FDA approves PDE4 inhibitor for IPF
4个月前
已完结
PALI-2108, A COLON TARGETED PDE4B INHIBITOR, RAPIDLY RESTORES IMMUNE-EPITHELIAL BALANCE IN ULCERATIVE COLITIS THROUGHGUT-SELECTIVE LYMPHOCYTE DEPLETION
4个月前
已完结
Discovery of pinoresinol dimethyl ether as a natural PDE4 inhibitor with anti-psoriatic effects
4个月前
已完结
Oral Roflumilast for Long-term Management of Behçet Spectrum Disorders: A Multicenter Observational Analysis
4个月前
已关闭
Safety, Tolerability, and Pharmacokinetics of Mufemilast, a PDE4 Inhibitor, in Healthy Participants: A First‐in‐Human Phase 1 Study
4个月前
已完结
Psychiatric Adverse Effects of Biologic and Novel Systemic Agents for Psoriasis and Inflammatory Bowel Disease: A Case Series and Literature Review
8个月前
已完结
Psychiatric Adverse Effects of Biologic and Novel Systemic Agents for Psoriasis and Inflammatory Bowel Disease: A Case Series and Literature Review
8个月前
已完结
皖公网安备34019202002308
